iX Biopharma42C 
$0.023.85%24h
3.85%24h
Global rank31059
Market cap$15.96M
Change 7d3.85%
YTD Performance-40.00%
SP500 benchmarkUnderperform
P/E0
P/S3.50
Revenue$4.56M
Earnings-$7.42M
Dividend yield-
Main Sector
Healthcare
Category
iX Biopharma (42C) Total Liabilities
42C Total Liabilities in 2022: $7.00M
According to iX Biopharma latest financial reports the total liabilities of 42C is $7.00M, an increase of 3.45% to 2022. At the end of 2022 company had $6.77M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that iX Biopharma is responsible for during its operational activities.
iX Biopharma (42C) Total Liabilities History from 2023 to 2022
-
Value:-
42C Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $7.00M | 3.45% |
| 2022 | $6.77M | 22.77% |
| 2021 | $5.51M | 4.87% |
| 2020 | $5.26M | 58.58% |
| 2019 | $3.32M | - |
View the Top Total Liabilies Stocks
